This content is machine translated Heart failure SGLT2 inhibitors – are the new preparations more than just good antidiabetic agents? SGLT2 inhibitors have been used successfully for some time in the treatment of diabetes mellitus. They are associated with effective blood glucose lowering through increased renal glucose excretion. But they…
View Post 4 min This content is machine translated GLP-1 receptor agonists Jack of all trades in the fight against type 2 diabetes GLP-1 receptor agonists (RA) have been used in the treatment of diabetic patients since 2005. For patients, their introduction was a milestone, as GLP-1 RAs have the great advantage of…
View Post 4 min This content is machine translated COVID-19 and chronic lung disease Up or down on meds? Is there an increased risk for COVID-19 patients if they have chronic lung disease? The answer to this is a resounding yes. Asthma patients are relatively well off compared to…
View Post 3 min This content is machine translated INOCA phenomenon and co. Late-Breaking News Highlights Despite the pandemic, the American College of Cardiology’s annual meeting, while not on-site in Chicago, still scored virtually. Numerous new findings with regard to both intervention strategies and pharmacological therapies…
View Post 6 min This content is machine translated RA therapy Let’s talk about JAKs The treatment of rheumatoid arthritis (RA) has made great progress over the past 20 years. This relates both to the range of drugs available and to developments in terms of…
View Post 3 min This content is machine translated Heart failure Empagliflozin Reduces Risk of Cardiovascular Death and Hospitalization Rate in Heart Failure Ingelheim, Germany and Indianapolis, USA – Results from the phase III EMPEROR-Reduced study in adults with heart failure with reduced ejection fraction (with and without diabetes) showed that empagliflozin was…
View Post 2 min This content is machine translated Migraine Avert headaches in advance Migraine is one of the most common of the more than 240 forms of headache and significantly restricts sufferers in their daily lives and quality of life. Although the number…
View Post 2 min This content is machine translated Spinal muscular atrophy SMA in adults: the road to personalized treatment Adults with spinal muscular atrophy form a clinically and genetically very heterogeneous group. A common feature is the progressive loss of motor anterior horn cells in the spinal cord, resulting…
View Post 2 min This content is machine translated Atrial fibrillation Early rhythm control aims for better outcomes In patients with newly diagnosed AF, early initiation of rhythm control may reduce cardiovascular outcomes. Therapy with antiarrhythmic drugs and/or catheter ablation reduced cardiovascular deaths, strokes, and hospitalizations caused by…
View Post 8 min This content is machine translated Systemic lupus erythematosus New possibilities for SLE therapy The core of the previous classification criteria for systemic lupus erythematosus (SLE) originated in 1982 and were only slightly modified in 1997. It is therefore high time to address the…
View Post 2 min This content is machine translated Multiple sclerosis Individual life situation in the focus of effective therapy Intensive research in the field of multiple sclerosis (MS) has led to the availability of different treatment options – depending on the form of the disease and its severity. Until…
